| Lead Manager/ | # of | Price Range | Dollar | SCOOP | ||
| New Filings (Proposed Symbol) | Joint-Lead Managers | Shares | Low | High | Volume | Ratings |
| Braeburn Pharmaceuticals (BBRX) | J.P. Morgan/ BofA Merrill Lynch | $100.00 | n.a. | |||
| Invitation Homes (INVH) | Deutsche Bank Securities/ J.P. Morgan/ BofA Merrill Lynch/ Goldman Sachs/ Wells Fargo Securities/ Credit Suisse/ Morgan Stanley/ RBC Capital Market | $100.00 | n.a. | |||
| Kimbell Royalty Partners, LP (KRP) | Raymond James/ RBC Capital Markets/ Stifel | $100.00 | n.a. | |||
| n.a. (not available) | ||||||
| Postponed | ||||||
| None | ||||||
| Withdrawn | ||||||
| Neiman Marcus Group (TBA) | TBA | $100.00 | n.a. | |||
| TBA (to be announced) | ||||||
| New Terms | ||||||
| None | ||||||
| IPOs Priced | Lead | Shares | Amount | Offer | Close | % |
| Week of Jan. 2, 2017 | Manager(s) | Offered | Raised | Price | 1/6/17 | Change |
| None | ||||||
